595 related articles for article (PubMed ID: 33132894)
1. Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer's Disease.
Zhu F; Li C; Chu F; Tian X; Zhu J
Front Aging Neurosci; 2020; 12():544235. PubMed ID: 33132894
[TBL] [Abstract][Full Text] [Related]
2. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
[TBL] [Abstract][Full Text] [Related]
3. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model.
Kim MS; Kim Y; Choi H; Kim W; Park S; Lee D; Kim DK; Kim HJ; Choi H; Hyun DW; Lee JY; Choi EY; Lee DS; Bae JW; Mook-Jung I
Gut; 2020 Feb; 69(2):283-294. PubMed ID: 31471351
[TBL] [Abstract][Full Text] [Related]
4. Brain-Gut-Microbiota Axis in Alzheimer's Disease.
Kowalski K; Mulak A
J Neurogastroenterol Motil; 2019 Jan; 25(1):48-60. PubMed ID: 30646475
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
Nagu P; Parashar A; Behl T; Mehta V
J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
[TBL] [Abstract][Full Text] [Related]
6. Microbiota-gut-brain axis and toll-like receptors in Alzheimer's disease.
Lin C; Zhao S; Zhu Y; Fan Z; Wang J; Zhang B; Chen Y
Comput Struct Biotechnol J; 2019; 17():1309-1317. PubMed ID: 31921396
[TBL] [Abstract][Full Text] [Related]
7. Antibiotics, gut microbiota, and Alzheimer's disease.
Angelucci F; Cechova K; Amlerova J; Hort J
J Neuroinflammation; 2019 May; 16(1):108. PubMed ID: 31118068
[TBL] [Abstract][Full Text] [Related]
8. Can Control Infections Slow Down the Progression of Alzheimer's Disease? Talking About the Role of Infections in Alzheimer's Disease.
Shi M; Li C; Tian X; Chu F; Zhu J
Front Aging Neurosci; 2021; 13():685863. PubMed ID: 34366826
[TBL] [Abstract][Full Text] [Related]
9. The Gut Microbiota and Alzheimer's Disease.
Jiang C; Li G; Huang P; Liu Z; Zhao B
J Alzheimers Dis; 2017; 58(1):1-15. PubMed ID: 28372330
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.
Liu S; Gao J; Zhu M; Liu K; Zhang HL
Mol Neurobiol; 2020 Dec; 57(12):5026-5043. PubMed ID: 32829453
[TBL] [Abstract][Full Text] [Related]
11. The Oral-Gut-Brain AXIS: The Influence of Microbes in Alzheimer's Disease.
Narengaowa ; Kong W; Lan F; Awan UF; Qing H; Ni J
Front Cell Neurosci; 2021; 15():633735. PubMed ID: 33935651
[TBL] [Abstract][Full Text] [Related]
12. Traditional Chinese medicine for the treatment of Alzheimer's disease: A focus on the microbiota-gut-brain axis.
Ma L; Jiang X; Huang Q; Chen W; Zhang H; Pei H; Cao Y; Wang H; Li H
Biomed Pharmacother; 2023 Sep; 165():115244. PubMed ID: 37516021
[TBL] [Abstract][Full Text] [Related]
13. Role of microbial dysbiosis in the pathogenesis of Alzheimer's disease.
Susmitha G; Kumar R
Neuropharmacology; 2023 May; 229():109478. PubMed ID: 36871788
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota and Immunotherapy for Alzheimer's Disease.
Dai CL; Liu F; Iqbal K; Gong CX
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499564
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota: Implications in Alzheimer's Disease.
He Y; Li B; Sun D; Chen S
J Clin Med; 2020 Jun; 9(7):. PubMed ID: 32610630
[TBL] [Abstract][Full Text] [Related]
16. A Review on the Protective Effects of Probiotics against Alzheimer's Disease.
Mishra V; Yadav D; Solanki KS; Koul B; Song M
Biology (Basel); 2023 Dec; 13(1):. PubMed ID: 38248439
[TBL] [Abstract][Full Text] [Related]
17. Time to test antibacterial therapy in Alzheimer's disease.
Panza F; Lozupone M; Solfrizzi V; Watling M; Imbimbo BP
Brain; 2019 Oct; 142(10):2905-2929. PubMed ID: 31532495
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of gut microbiota dysbiosis in neuroinflammation and neurodegeneration.
Solanki R; Karande A; Ranganathan P
Front Neurol; 2023; 14():1149618. PubMed ID: 37255721
[TBL] [Abstract][Full Text] [Related]
19. Injection of amyloid-β to lateral ventricle induces gut microbiota dysbiosis in association with inhibition of cholinergic anti-inflammatory pathways in Alzheimer's disease.
Qian XH; Liu XL; Chen G; Chen SD; Tang HD
J Neuroinflammation; 2022 Sep; 19(1):236. PubMed ID: 36171620
[TBL] [Abstract][Full Text] [Related]
20. Manipulation of the diet-microbiota-brain axis in Alzheimer's disease.
Lee D; Lee VM; Hur SK
Front Neurosci; 2022; 16():1042865. PubMed ID: 36408394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
